| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Autistic Disorder | |||||
| 2 | More general conditions related to this trial | ||||
| Child Development Disorders, Pervasive | |||||
| Mental Disorders | |||||
| Mental Disorders Diagnosed in Childhood | |||||
| 3 | Interventions listed in this trial | ||||
| Risperidone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antipsychotic Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Dopamine Agents | |||||
| Dopamine Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Antagonists | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Mental Health (NIMH) | |||||
|
